Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial

BACKGROUND:The use of poly-L-lactide acid-based bioresorbable scaffolds is limited in daily clinical practice because of safety concerns and lack of physiological benefit. Magnesium-based bioresorbable scaffold (MgBRS) presents a short resorption period (

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 2019-12, Vol.140 (23), p.1904-1916
Hauptverfasser:	Sabaté, Manel, Alfonso, Fernando, Cequier, Angel, Romaní, Sebastián, Bordes, Pascual, Serra, Antonio, Iñiguez, Andrés, Salinas, Pablo, García del Blanco, Bruno, Goicolea, Javier, Hernández-Antolín, Rosana, Cuesta, Javier, Gómez-Hospital, Joan Antoni, Ortega-Paz, Luis, Gomez-Lara, Josep, Brugaletta, Salvatore
Format:	Artikel
Sprache:	eng
Schlagworte:	Absorbable Implants Acetylcholine - pharmacology Aged Angioplasty, Balloon, Coronary Coronary Angiography Coronary Restenosis - epidemiology Drug-Eluting Stents Endothelium, Vascular - drug effects Endothelium, Vascular - physiopathology Female Humans Incidence Magnesium Male Middle Aged Nitroglycerin - pharmacology Polyesters Risk Factors Sample Size Sirolimus - administration & dosage Sirolimus - therapeutic use ST Elevation Myocardial Infarction - drug therapy ST Elevation Myocardial Infarction - surgery Thrombectomy Tissue Scaffolds Vasodilation - drug effects Vasodilator Agents - therapeutic use Vasomotor System - physiopathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	BACKGROUND:The use of poly-L-lactide acid-based bioresorbable scaffolds is limited in daily clinical practice because of safety concerns and lack of physiological benefit. Magnesium-based bioresorbable scaffold (MgBRS) presents a short resorption period (
ISSN:	0009-7322 1524-4539
DOI:	10.1161/CIRCULATIONAHA.119.043467